Calcification levels in aorta (left) and muzzle skin biopsies containing the dermal sheath of vibrissae (middle) of 5-week-old mice dosed with 300 µg of anti-CD4 mAb at 2 weeks of age and 100 µg at 3 and 4 weeks of age. Body weights of these mice was monitored (right). Each treatment group consists of a cohort of n=5 (vehicle-treated Asj-2J) or n=6 (anti-CD4-treated Asj-2J) male mice/group.All data is graphed as mean +/-S.E.M. All statistical analyses were performed relative to vehicle-treated Asj-2J hom mice. *P < 0.05, **P < 0.005, and *** P < 0.0005 (by one-way ANOVA, followed by Tukey's multiple comparison test). Mice were dosed beginning at 2 week of age with 2100 U/kg rhENPP1 (lot #2) or vehicle EOD by subcutaneous injection for a period of 6 weeks. Tissues and plasma were collected 1 day after the final dose. (A) Calcification levels in aorta and muzzle skin containing the dermal sheath of vibrissae were measured using a quantitative calcium assay. (B) Plasma PP i and ADA levels were measured in mice. Each treatment group consists of a cohort of n=8 mice/group and all data is graphed as mean +/-S.E.M. *P < 0.05, **P < 0.005, and *** P < 0.0005 (by one-way ANOVA, followed by Tukey's multiple comparison test).
